scispace - formally typeset
Journal ArticleDOI

Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.

Reads0
Chats0
TLDR
Overall, sustained intense levels of SP resistance mutations and a recovery of CQ susceptible parasites were found in this study following 7 years and 14 years of drug withdrawal from use, respectively.
About
This article is published in Acta Tropica.The article was published on 2016-12-01. It has received 28 citations till now. The article focuses on the topics: Sulfadoxine/pyrimethamine & Amodiaquine.

read more

Citations
More filters
Journal ArticleDOI

Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.

TL;DR: Recent advances in understanding how antimalarials act and how resistance develops are reviewed, and new strategies for effectively combatting resistance, optimizing treatment and advancing the global campaign to eliminate malaria are discussed.
Journal ArticleDOI

Persistence of chloroquine resistance alleles in malaria endemic countries: a systematic review of burden and risk factors.

TL;DR: The prevalence of chloroquine resistance alleles among Plasmodium falciparum parasites have steadily declined since discontinuation of chlorquine use, however, Pfcrt K76T and Pfmdr-1 N86Y mutations still persist at moderate frequencies in most malaria affected countries.
Journal ArticleDOI

The genomic architecture of antimalarial drug resistance

TL;DR: The ability of malaria parasites to develop resistance is primarily due to the high numbers of parasites in the infected person's bloodstream during the asexual blood stage of infection in conjunction with the mutability of their genomes as discussed by the authors.
Journal ArticleDOI

Putting evolution in elimination: Winning our ongoing battle with evolving malaria mosquitoes and parasites.

TL;DR: The evolutionary consequences of the way the authors currently implement antimalarial interventions, which is leading to resistance and may ultimately lead to control failure, are discussed, but also how evolutionary principles can be applied to extend the lifespan of current and novel interventions are discussed.
Journal ArticleDOI

pfmdr1 (Plasmodium falciparum multidrug drug resistance gene 1): a pivotal factor in malaria resistance to artemisinin combination therapies

TL;DR: Pfmdr 1 has emerged as the central gene in P. falciparum ACT resistance, and unveiling situations of drug collateral sensitivity associated with specific pfmdr1 genetic variation will provide opportunities for personalized optimal therapy options.
References
More filters
Journal ArticleDOI

Spread of Artemisinin Resistance in Plasmodium falciparum Malaria

Elizabeth A. Ashley, +82 more
TL;DR: Prolonged courses of artemisinin-based combination therapies are currently efficacious in areas where standard 3-day treatments are failing, and the incidence of pretreatment and post-treatment gametocytemia was higher among patients with slow parasite clearance, suggesting greater potential for transmission.
Journal ArticleDOI

Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance

TL;DR: The determinant of verapamil-reversible chloroquine resistance (CQR) in a Plasmodium falciparum genetic cross maps to a 36 kb segment of chromosome 7 that harbors a 13-exon gene, pfcrt, having point mutations that associate completely with CQR in parasite lines from Asia, Africa, and South America.
Journal ArticleDOI

Penicillinase-producing Neisseria gonorrhoeae.

TL;DR: Penicillin sensitivity testing of the responsible strain of Neisseria gonorrhoeae prompted repeated failure of penicillin G treatment in a man with gonorrhoeal urethritis showed complete resistance to 10 mug of peniillin G.
Related Papers (5)